{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-132699","form_type":"8-K","ticker":"INDV","cik":"0001625297","company_name":"Indivior Pharmaceuticals, Inc.","filed_at":"2025-06-02T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.105201+00:00","generated_at":"2026-05-20T02:56:51.981291+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"low","headline":"Indivior posts updated corporate presentation June 2025; content not fully disclosed","bullets":["Company added 'Corporate Presentation June 2025' to its investor relations website on June 2, 2025.","Presentation furnished as Exhibit 99.1; full text not provided in SEC filing excerpt.","No specific financial guidance, clinical data, or operational updates available from truncated exhibit.","Investors should refer to the full presentation on Indivior's IR page for details."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-132699","json":"https://secwatch.observer/filing/0001193125-25-132699.json","markdown":"https://secwatch.observer/filing/0001193125-25-132699.md","text":"https://secwatch.observer/filing/0001193125-25-132699.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1625297/000119312525132699/0001193125-25-132699-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1625297/000119312525132699/d949841d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-20T02:56:51.981291+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}